Spots Global Cancer Trial Database for prostate cancer
Every month we try and update this database with for prostate cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Using Magnetic Resonance Imaging (MRI) to Guide Differential-Dose Prostate Brachytherapy | NCT01913197 | Prostate Cancer | An MRI-based te... | 18 Years - | St. Luke's-Roosevelt Hospital Center | |
| A Prospective Randomized Trial of Prostate Biopsy Protocols Comparing the Vienna Nomogram and a Standard 10-core Biopsy Scheme | NCT01752140 | Prostate Cancer | 10-core prostat... Vienna nomogram... | - | Hospital de Santa Maria, Portugal | |
| Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors | NCT00667641 | Breast Cancer Colorectal Canc... Head and Neck C... Lung Cancer Melanoma (Skin) Ovarian Cancer Pancreatic Canc... Prostate Cancer Unspecified Adu... | bortezomib paclitaxel | 18 Years - | Rutgers, The State University of New Jersey | |
| Radium-223 in Combination With Enzalutamide | NCT02225704 | Prostate Cancer | Radium-223 and ... | 18 Years - | Cancer Trials Ireland | |
| Validation of ClarityDX Prostate as a Reflex Test to Refine the Prediction of Clinically-significant Prostate Cancer | NCT03957252 | Prostate Cancer | Blood test: Cla... | 40 Years - 75 Years | Nanostics | |
| Special Drug Use Surveillance of Leuplin PRO for Injection Kit 22.5 mg for "Prostate Cancer" | NCT03209492 | Prostate Cancer | Leuprorelin ace... | - | Takeda | |
| Patient Preference Survey for Radiation Oncologists | NCT00595218 | Breast Cancer Prostate Cancer Lung Cancer | Physician behav... Patient Prefere... | 18 Years - | University of Pittsburgh | |
| Retrospective Study to Assess Real-Life Use of The Long Acting GnRH Agonist as Prostate Cancer Treatment | NCT06217770 | Prostate Cancer | 18 Years - | Chinese University of Hong Kong | ||
| Abiraterone Post Ketoconazole for Prostate Cancer | NCT01199146 | Prostate Cancer | Abiraterone ace... | 18 Years - | University of California, San Francisco | |
| AZD5153 in Patients With Relapsed or Refractory Solid Tumors, Including Lymphomas | NCT03205176 | Malignant Solid... Lymphoma Ovarian Cancer Breast Cancer Pancreatic Canc... Prostate Cancer | AZD5153 Olaparib | 18 Years - 130 Years | AstraZeneca | |
| Exogenous Testosterone Plus Dutasteride for the Treatment of Castrate Metastatic Prostate Cancer | NCT00853697 | Prostate Cancer Castration-resi... | testosterone (A... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Predicting Prostate Biopsy Results With Biomarkers and mpMRI. | NCT03730324 | Prostate Cancer | mpMRI Urine and plasm... | 18 Years - 75 Years | Odense University Hospital | |
| Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence | NCT00003645 | Prostate Cancer | Flutamide Leuprolide Acet... | - | M.D. Anderson Cancer Center | |
| Detection of Prostate Cancer With Non-invasive Method Based on DNA Methylation of Circulated Tumor DNA, PBMC | NCT03494803 | Prostate Cancer Prostate Adenoc... Prostate Cancer... | 18 Years - 90 Years | HKGepitherapeutics | ||
| Docetaxel/Prednisone Versus Docetaxel/Prednisone and Enzalutamide in Castration-Resistant Prostate Cancer | NCT02685267 | Prostate Cancer | Docetaxel Enzalutamide Prednisone | 18 Years - | Prostate Cancer Clinical Trials Consortium | |
| Prospective Cohort Study of the Ability of MRI/DTI to Diagnose Prostate Cancer | NCT02934776 | Magnetic Resona... | MRI machine | 18 Years - 90 Years | Rabin Medical Center | |
| Prostate Cancer Intervention Versus Observation Trial (PIVOT) | NCT00007644 | Prostate Cancer | Radical prostat... | - 75 Years | VA Office of Research and Development | |
| Multiparametric MRI in Men With Prostate Cancer Enrolled in Active Surveillance | NCT03648359 | Prostatic Neopl... | multiparametric... | 18 Years - 75 Years | Herlev Hospital | |
| Salvage Prostatectomy After Radiotherapy | NCT00791115 | Prostate Cancer | whole-mount sec... | 18 Years - | University Health Network, Toronto | |
| SBRT for Oligometastatic Lymph Node Recurrence in Prostate Cancer: a Single Institution Experience | NCT03604211 | Prostate Cancer... Prostate Cancer Lymph Node Meta... | Cyberknife Radi... | 18 Years - 85 Years | Kantonsspital Graubuenden | |
| Neoadjuvant Bevacizumab Plus Docetaxel in High Risk Patients With Prostate Cancer Undergoing Radical Prostatectomy | NCT00321646 | Prostate Cancer Adenocarcinoma ... | Bevacizumab Docetaxel | 18 Years - | Dana-Farber Cancer Institute | |
| Focal ExAblate MR-Guided Focused Ultrasound Treatment for Management of Organ-Confined Intermediate Risk Prostate Cancer | NCT02968784 | Prostate Cancer | ExAblate MRgFUS | 50 Years - | InSightec | |
| A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study | NCT02960022 | Prostate Cancer | enzalutamide abiraterone ace... prednisone | 18 Years - | Astellas Pharma Inc | |
| Calcitriol and Dexamethasone Before Radical Prostatectomy in Treating Patients With Localized Adenocarcinoma (Cancer) of the Prostate | NCT00084864 | Prostate Cancer | calcitriol dexamethasone clinical observ... | 18 Years - 120 Years | Roswell Park Cancer Institute | |
| Multicenter Study of Hypofractionated Postoperative Radiotherapy in Patients Diagnosed With Prostate Carcinoma | NCT04484038 | Prostate Cancer | hypofractionate... | 18 Years - | Grupo de Investigación Clínica en Oncología Radioterapia | |
| High Dose Rate Prostate Brachytherapy as Salvage for Locally Recurrent Prostate Cancer Previously Treated With External Beam Radiotherapy | NCT00604526 | Prostate Cancer | High dose rate ... | 18 Years - 85 Years | Memorial Sloan Kettering Cancer Center | |
| Atorvastatin Calcium and Celecoxib in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancer | NCT01220973 | Prostate Cancer | atorvastatin ca... celecoxib laboratory biom... | 18 Years - 120 Years | Rutgers, The State University of New Jersey | |
| Multi-site Decision Impact Study for Decipher | NCT02034825 | Prostate Cancer | Decipher Questi... | - | GenomeDx Biosciences Corp | |
| Impact of Peri-operative tEstosterone Levels on oNcological and Functional Outcomes in RadiCal prostatEctomy | NCT04833426 | Prostatic Neopl... Hypogonadism Testosterone De... | Testosterone ge... Placebo | 18 Years - | Canisius-Wilhelmina Hospital | |
| Carbohydrate Restriction and Prostate Cancer Growth | NCT01763944 | Prostate Cancer | Low carbohydrat... | 20 Years - | Duke University | |
| Preop Laxatives in Robotic Urologic Surgery | NCT05805436 | Prostate Cancer Kidney Cancer Constipation | Polyethylene Gl... | 30 Years - 100 Years | University of Iowa | |
| Far Infrared Radiation Treatment for Prostate Cancer | NCT00573820 | Prostatic Neopl... | Far Infrared Ra... | - | GAAD Medical Research Institute Inc. | |
| OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors | NCT00471432 | Bladder Cancer Breast Cancer Kidney Cancer Lung Cancer Ovarian Cancer Prostate Cancer Unspecified Adu... | custirsen sodiu... docetaxel pharmacological... | 18 Years - 120 Years | Canadian Cancer Trials Group | |
| Hormone Therapy Followed By Internal Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer | NCT00032006 | Prostate Cancer | brachytherapy radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Integrated Care Pathway in Oncology (PASSION) | NCT04235556 | Colon Cancer Gastric Cancer Pancreatic Canc... Thoracic Neopla... Breast Cancer Ovarian Cancer Bladder Cancer Prostate Cancer | Care pathway un... | 18 Years - 80 Years | Assistance Publique - Hôpitaux de Paris | |
| Optical Tomography in Prostate Cancer | NCT03215992 | Prostate Cancer | Diffuse Optical... | 18 Years - 99 Years | Columbia University | |
| A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate Cancer | NCT00672009 | Prostatic Disea... Genital Neoplas... Urogenital Neop... Genital Disease... Adenocarcinoma Prostatic Neopl... Neoplasms, Glan... Carcinoma | Ixabepilone | - | Cedars-Sinai Medical Center | |
| Investigation of Protein Biomarkers of Prostate Cancer | NCT00323180 | Prostate Cancer | 18 Years - | University of New Mexico | ||
| CARINAE for Stress Relief in Perioperative Care | NCT05184725 | Psychological S... Cardiopulmonary... Coronary Artery... Cardiac Valve R... Hip Replacement Orthognathic Su... Scoliosis Knee Replacemen... Prostate Cancer Kidney Cancer Bladder Cancer | SaMD CARINAE | 8 Years - | Adhera Health, Inc. | |
| Ferumoxtran-10-enhanced MRI in Prostate Cancer Patients | NCT04261777 | Prostate Cancer Metastasis Prostatectomy | Ferrotran® (Fer... | 18 Years - | Saving Patients' Lives Medical B.V. | |
| Whole Body Magnetic Resonance Imaging Study | NCT04117594 | Advanced Prosta... | WB-MRI | 18 Years - | Royal Marsden NHS Foundation Trust | |
| Stereotactic Radiation Therapy in Treating Patients With Prostate Cancer | NCT00619515 | Prostate Cancer | questionnaire a... implanted fiduc... stereotactic ra... | - 120 Years | Case Comprehensive Cancer Center | |
| Biochemical Recurrence Rate of Radical Prostatectomy Combined With Neoadjuvant and Adjuvant Chemotherapy in High Risk Prostate Cancer | NCT01530295 | Prostate Cancer | DOCETAXEL | - | Asan Medical Center | |
| Active Surveillance for Low Risk Prostate Cancer | NCT04146077 | Prostate Cancer Prostate Adenoc... | 50 Years - 75 Years | I.M. Sechenov First Moscow State Medical University | ||
| MR-target Biopsy vs. TRUS-biopsy in Men With Suspicious Prostate Cancer | NCT04320147 | Prostate Cancer | Artemia | 50 Years - 80 Years | Asan Medical Center | |
| Economic Analyses of the REDUCE Trial | NCT01337258 | Neoplasms, Pros... Benign Prostati... Cancer | Dutasteride Placebo | 50 Years - 75 Years | GlaxoSmithKline | |
| Using Ultrasound Spectrum Analysis (USA) to Guide Dose Escalated Prostate Brachytherapy | NCT01227642 | Clinical Stage ... Prostate Brachy... Transrectal Pro... | An ultrasound-b... pre-implant tra... ultrasound-base... | 18 Years - | Beth Israel Medical Center | |
| Sequencing of Radium-223 and Docetaxel in Symptomatic Bone-only Metastatic Castration-resistant Prostate Cancer | NCT03230734 | Metastatic Cast... | Radium-223 Docetaxel | 18 Years - | Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori | |
| Lifestyle Intervention in Patients With Metastatic Prostate Cancer | NCT05850182 | Prostate Cancer | Lifestyle inter... | 18 Years - | Oncology Institute of Southern Switzerland | |
| Comparative Effectiveness Analysis of Surgery and Radiation (CEASAR) for Localized Prostate Cancer | NCT01326286 | Prostate Cancer | 18 Years - 79 Years | Vanderbilt University Medical Center | ||
| Open Registry Measuring Impact of Genomic Testing on Treatment of Prostate Cancer Patients | NCT01954004 | Prostate Cancer | 18 Years - | Myriad Genetic Laboratories, Inc. | ||
| A Study to Assess the Efficacy of Tadalafil to Treat Erectile Dysfunction After Radiotherapy of Prostate Cancer | NCT00122499 | Prostate Cancer Erectile Dysfun... | tadalafil | 18 Years - | Erasmus Medical Center | |
| Efficacy and Safety of Darolutamide in Combination With Androgen-Deprivation Therapy in Prostate Cancer Patients With Lymph Node-positive After Radical Prostatectomy: A Prospective Observational Cohort Study | NCT06435702 | Prostate Cancer | Darolutamide in... androgen depriv... | 18 Years - 80 Years | Peking University Third Hospital | |
| A Study of Leuprolide to Treat Prostate Cancer | NCT00626431 | Prostate Cancer | Leuprolide acet... Leuprolide acet... | 18 Years - | Abbott | |
| Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy | NCT04068896 | Pancreatic Canc... Metastatic Cast... Bladder Cancer Melanoma Non-small Cell ... Colorectal Canc... Gastric Cancer Esophageal Canc... Ovarian Cancer Head Neck Squam... Prostate Cancer | NGM120 NGM120 NGM120 NGM120 NGM120 NGM120 Placebo | 18 Years - | NGM Biopharmaceuticals, Inc | |
| Biopsy Study Comparing MRI and Ultrasound Soft Image Fusion Guided Biopsies and Gold Standard Prostate Biopsies. | NCT01455792 | Prostate Cancer | Biopsies using ... Gold standard b... | - | Oslo University Hospital | |
| Healthy Bones Study | NCT01973673 | Locally Advance... | Bone health edu... | 18 Years - | University Health Network, Toronto | |
| Effect of Optimized PEEP on Mechanical Ventilation During Robot Assisted Laparoscopic Prostatectomy | NCT05669443 | Prostate Cancer | conventional PE... optimized PEEP | 20 Years - 70 Years | Gangnam Severance Hospital | |
| An Open-Label Study of YM155 + Docetaxel in Subjects With Advanced Hormone Refractory Prostate Cancer and Other Solid Tumors | NCT00514267 | Prostate Cancer Tumors | YM 155 Docetaxel Prednisone | 18 Years - | Astellas Pharma Inc | |
| RAD001 and Bicalutamide for Androgen Independent Prostate Cancer | NCT00630344 | Prostate Cancer | RAD001 Bicalutamide | 18 Years - | Dana-Farber Cancer Institute | |
| A Study Using Available Data to Learn to What Extent Patients With Prostate Cancer Who Received Second Generation Androgen Receptor Inhibitors Took Their Medication as Prescribed or Stopped Taking Their Medication Completely | NCT05202301 | Prostate Cancer | Darolutamide (N... Enzalutamide Apalutamide | 18 Years - | Bayer | |
| Familial Prostate Cancer | NCT00001377 | Neoplastic Synd... Prostatic Neopl... | - | National Institutes of Health Clinical Center (CC) | ||
| Validation of Software-based Fusion of Ultrasound and MRI Images of the Prostate | NCT02882958 | Prostate Cancer | 18 Years - | Massachusetts General Hospital | ||
| Developing Inclusive Support and Intervention for Spanish-speaking Latiné Prostate Cancer Survivors | NCT06435871 | Prostate Cancer | Expanded Prosta... | 18 Years - | Case Comprehensive Cancer Center | |
| Quality of Life Study for Prostate Cancer Patients | NCT00561444 | Prostate Cancer | Questionnaire | 18 Years - | M.D. Anderson Cancer Center | |
| Hypofractionated Radiotherapy for Prostate Cancer | NCT03851926 | Prostate Cancer | Hypofractionate... | 18 Years - | Consorci Sanitari de Terrassa | |
| Phase II Study of Dasatinib (BMS-354825) for Androgen-deprived Progressive Prostate Cancer | NCT00385580 | Prostate Cancer | dasatinib dasatinib | 18 Years - | Bristol-Myers Squibb | |
| Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases | NCT00079001 | Metastatic Canc... Prostate Cancer | zoledronic acid placebo androgen depriv... GnRH agonist Calcium supplem... Vitamin D | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Magnetic Resonance Spectroscopic Imaging Study of Prostatic Fats to Distinguish the Difference Between High and Low Risk Prostate Cancer | NCT01780701 | Prostate Cancer | Magnetic Resona... | 21 Years - | OHSU Knight Cancer Institute | |
| Study of Tissue, Blood, and Urine Samples From Patients With Advanced Prostate Cancer | NCT00967889 | Prostate Cancer | gene expression... protein analysi... biologic sample... laboratory biom... | - | National Cancer Institute (NCI) | |
| Trial of Docetaxel-Samarium in Patients With Hormone-Refractory Advanced Prostate Cancer | NCT00126230 | Prostate Cancer | docetaxel and s... | 18 Years - 80 Years | Gustave Roussy, Cancer Campus, Grand Paris | |
| 3-Tesla MRI in Finding Tumors in Patients With Known or Suspected Prostate Cancer | NCT01653093 | Prostate Cancer | 3-Tesla magneti... diffusion-weigh... dynamic contras... magnetic resona... | - | University of Cincinnati | |
| A Comparison of Aerobic and Resistance Exercise to Counteract Treatment Side Effects in Men With Prostate Cancer | NCT05156424 | Exercise Prostate Cancer | Exercise | 18 Years - | Waterford Instituate of Technology | |
| Investigating Efficacy and Safety of Two Degarelix Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Ablation Therapy | NCT00468286 | Prostate Cancer | Degarelix Degarelix | 18 Years - | Ferring Pharmaceuticals | |
| Study of Bortezomib and Docetaxel for Patients With Hormone Refractory Prostate Cancer | NCT00183937 | Prostate Cancer | PS 341 Docetaxel | 18 Years - | University of Southern California | |
| Effectiveness of Cryotherapy Study for Prostate Cancer | NCT04978519 | Prostate Cancer | Cryotherapy | 40 Years - 85 Years | Chinese University of Hong Kong | |
| GE-148-002: A Phase 2, Open-label, Single-Center Study to Assess GE-148 (18F) Injection PET Imaging to Detect Localized Prostate Cancer | NCT01176513 | Prostate Cancer | GE-148 (18F) | 18 Years - | GE Healthcare | |
| Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer | NCT00601406 | Breast Cancer Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Primary Periton... Prostate Cancer Sarcoma Vaginal Cancer Vulvar Cancer | gene expression... gene rearrangem... polymorphism an... laboratory biom... radiation thera... | - | National Cancer Institute (NCI) | |
| Phase II Study of SBRT as Treatment for Oligometastases in Prostate Cancer | NCT02192788 | Oligometastatic... | Stereotactic Bo... | 18 Years - | Grupo de Investigación Clínica en Oncología Radioterapia | |
| 3T Endorectal Magnetic Resonance Spectroscopic Imaging (MRSI) of Prostate | NCT00429338 | Prostate Cancer | AIR-MRSI PFC-MRSI | 18 Years - | M.D. Anderson Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
